ACRS Q1 2018 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1M

Gross Profit

$151,00013.5% margin

Operating Income

-$31M-2768.2% margin

Net Income

-$30M-2703.8% margin

EPS (Diluted)

$-0.98

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$221M

Total Liabilities

$20M

Stockholders' Equity

$200M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$151,000	$0	—
Operating Income	-$31M	-$13M	-139.4%
Net Income	-$30M	-$13M	-140.7%

Revenue Segments

Contract Research Segment

$3M100%